nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PTGS1—Diphenhydramine—atopic dermatitis	0.123	0.341	CbGbCtD
Mesalazine—PTGS2—Triamcinolone—atopic dermatitis	0.101	0.28	CbGbCtD
Mesalazine—PTGS2—Betamethasone—atopic dermatitis	0.0866	0.24	CbGbCtD
Mesalazine—PTGS2—Dexamethasone—atopic dermatitis	0.0504	0.14	CbGbCtD
Mesalazine—PPARG—dermis—atopic dermatitis	0.0155	0.326	CbGeAlD
Mesalazine—CHUK—skin of body—atopic dermatitis	0.00479	0.1	CbGeAlD
Mesalazine—Olsalazine—IFNG—atopic dermatitis	0.00457	1	CrCbGaD
Mesalazine—PTGS2—skin epidermis—atopic dermatitis	0.00334	0.0701	CbGeAlD
Mesalazine—IKBKB—skin of body—atopic dermatitis	0.00325	0.0683	CbGeAlD
Mesalazine—PPARG—neck—atopic dermatitis	0.00313	0.0656	CbGeAlD
Mesalazine—CHUK—head—atopic dermatitis	0.00312	0.0655	CbGeAlD
Mesalazine—MPO—skin of body—atopic dermatitis	0.00228	0.0479	CbGeAlD
Mesalazine—IKBKB—head—atopic dermatitis	0.00212	0.0445	CbGeAlD
Mesalazine—PPARG—skin of body—atopic dermatitis	0.00202	0.0425	CbGeAlD
Mesalazine—ALOX5—head—atopic dermatitis	0.00176	0.0369	CbGeAlD
Mesalazine—MPO—head—atopic dermatitis	0.00149	0.0312	CbGeAlD
Mesalazine—PPARG—head—atopic dermatitis	0.00132	0.0277	CbGeAlD
Mesalazine—PPARG—Everolimus—Pimecrolimus—atopic dermatitis	0.0012	0.149	CbGdCrCtD
Mesalazine—PPARG—Everolimus—Tacrolimus—atopic dermatitis	0.0012	0.149	CbGdCrCtD
Mesalazine—PTGS1—skin of body—atopic dermatitis	0.00108	0.0227	CbGeAlD
Mesalazine—PTGS2—skin of body—atopic dermatitis	0.00103	0.0217	CbGeAlD
Mesalazine—PTGS2—Fluocinonide—Desonide—atopic dermatitis	0.000931	0.116	CbGdCrCtD
Mesalazine—PTGS2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	0.000724	0.09	CbGdCrCtD
Mesalazine—PTGS1—head—atopic dermatitis	0.000706	0.0148	CbGeAlD
Mesalazine—PTGS2—head—atopic dermatitis	0.000675	0.0142	CbGeAlD
Mesalazine—PTGS2—Fluocinonide—Mometasone—atopic dermatitis	0.000578	0.0718	CbGdCrCtD
Mesalazine—PTGS2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.00045	0.0559	CbGdCrCtD
Mesalazine—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.000437	0.0543	CbGdCrCtD
Mesalazine—PTGS2—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000349	0.0433	CbGdCrCtD
Mesalazine—PTGS2—Fluocinonide—Methylprednisolone—atopic dermatitis	0.000345	0.0429	CbGdCrCtD
Mesalazine—PTGS2—Fluocinonide—Betamethasone—atopic dermatitis	0.00034	0.0422	CbGdCrCtD
Mesalazine—PTGS2—Fluocinonide—Dexamethasone—atopic dermatitis	0.00034	0.0422	CbGdCrCtD
Mesalazine—PTGS2—Fluocinonide—Triamcinolone—atopic dermatitis	0.000332	0.0412	CbGdCrCtD
Mesalazine—PTGS2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	0.000208	0.0259	CbGdCrCtD
Mesalazine—PTGS2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	0.000205	0.0255	CbGdCrCtD
Mesalazine—PTGS2—Fluticasone Propionate—Betamethasone—atopic dermatitis	0.000205	0.0255	CbGdCrCtD
Mesalazine—PTGS2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	0.0002	0.0249	CbGdCrCtD
Mesalazine—IKBKB—Innate Immune System—CARD11—atopic dermatitis	0.000127	0.000519	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000127	0.000517	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	0.000127	0.000515	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MS4A2—atopic dermatitis	0.000126	0.000513	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—NFKBIA—atopic dermatitis	0.000126	0.000512	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—TNF—atopic dermatitis	0.000125	0.000511	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	0.000124	0.000506	CbGpPWpGaD
Mesalazine—CHUK—Immune System—DEFB1—atopic dermatitis	0.000124	0.000504	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—NGF—atopic dermatitis	0.000124	0.000504	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL18—atopic dermatitis	0.000123	0.000502	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CARD11—atopic dermatitis	0.000122	0.000498	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—atopic dermatitis	0.000122	0.000498	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TNF—atopic dermatitis	0.000122	0.000498	CbGpPWpGaD
Mesalazine—IKBKB—Activated TLR4 signalling—MAPK8—atopic dermatitis	0.000122	0.000497	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000121	0.000494	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	0.000121	0.000493	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—CD4—atopic dermatitis	0.000119	0.000486	CbGpPWpGaD
Mesalazine—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	0.000119	0.000485	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000119	0.000484	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	0.000118	0.000478	CbGpPWpGaD
Mesalazine—Rash—Tacrolimus—atopic dermatitis	0.000117	0.000353	CcSEcCtD
Mesalazine—Dermatitis—Tacrolimus—atopic dermatitis	0.000117	0.000352	CcSEcCtD
Mesalazine—Shock—Prednisolone—atopic dermatitis	0.000117	0.000351	CcSEcCtD
Mesalazine—Cough—Triamcinolone—atopic dermatitis	0.000117	0.000351	CcSEcCtD
Mesalazine—Headache—Tacrolimus—atopic dermatitis	0.000117	0.00035	CcSEcCtD
Mesalazine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000116	0.000349	CcSEcCtD
Mesalazine—Oedema—Hydrocortisone—atopic dermatitis	0.000116	0.000349	CcSEcCtD
Mesalazine—Tachycardia—Prednisolone—atopic dermatitis	0.000116	0.000349	CcSEcCtD
Mesalazine—Hypertension—Triamcinolone—atopic dermatitis	0.000116	0.000348	CcSEcCtD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	0.000116	0.00047	CbGpPWpGaD
Mesalazine—Hypertension—Methylprednisolone—atopic dermatitis	0.000115	0.000347	CcSEcCtD
Mesalazine—Infection—Hydrocortisone—atopic dermatitis	0.000115	0.000347	CcSEcCtD
Mesalazine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000115	0.000345	CcSEcCtD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	0.000115	0.000467	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000115	0.000466	CbGpPWpGaD
Mesalazine—Shock—Hydrocortisone—atopic dermatitis	0.000114	0.000343	CcSEcCtD
Mesalazine—Myalgia—Triamcinolone—atopic dermatitis	0.000114	0.000343	CcSEcCtD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000114	0.000464	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	0.000114	0.000464	CbGpPWpGaD
Mesalazine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000114	0.000342	CcSEcCtD
Mesalazine—Arthralgia—Methylprednisolone—atopic dermatitis	0.000114	0.000342	CcSEcCtD
Mesalazine—Myalgia—Methylprednisolone—atopic dermatitis	0.000114	0.000342	CcSEcCtD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—TNF—atopic dermatitis	0.000114	0.000463	CbGpPWpGaD
Mesalazine—Eye disorder—Prednisone—atopic dermatitis	0.000114	0.000341	CcSEcCtD
Mesalazine—Anxiety—Methylprednisolone—atopic dermatitis	0.000113	0.000341	CcSEcCtD
Mesalazine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000113	0.000341	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000113	0.00034	CcSEcCtD
Mesalazine—Skin disorder—Hydrocortisone—atopic dermatitis	0.000113	0.000339	CcSEcCtD
Mesalazine—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000113	0.000339	CcSEcCtD
Mesalazine—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000113	0.000339	CcSEcCtD
Mesalazine—Discomfort—Triamcinolone—atopic dermatitis	0.000113	0.000339	CcSEcCtD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	0.000113	0.000459	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	0.000113	0.000459	CbGpPWpGaD
Mesalazine—Discomfort—Methylprednisolone—atopic dermatitis	0.000113	0.000338	CcSEcCtD
Mesalazine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000112	0.000337	CcSEcCtD
Mesalazine—IKBKB—Immune System—DEFB1—atopic dermatitis	0.000112	0.000457	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—NGF—atopic dermatitis	0.000112	0.000457	CbGpPWpGaD
Mesalazine—Dry mouth—Triamcinolone—atopic dermatitis	0.000112	0.000335	CcSEcCtD
Mesalazine—Angioedema—Dexamethasone—atopic dermatitis	0.000111	0.000334	CcSEcCtD
Mesalazine—Angioedema—Betamethasone—atopic dermatitis	0.000111	0.000334	CcSEcCtD
Mesalazine—CHUK—BDNF signaling pathway—MAPK8—atopic dermatitis	0.000111	0.000451	CbGpPWpGaD
Mesalazine—Anorexia—Hydrocortisone—atopic dermatitis	0.000111	0.000333	CcSEcCtD
Mesalazine—Nausea—Tacrolimus—atopic dermatitis	0.000111	0.000332	CcSEcCtD
Mesalazine—Angiopathy—Prednisone—atopic dermatitis	0.00011	0.000332	CcSEcCtD
Mesalazine—Confusional state—Methylprednisolone—atopic dermatitis	0.00011	0.000331	CcSEcCtD
Mesalazine—Immune system disorder—Prednisone—atopic dermatitis	0.00011	0.00033	CcSEcCtD
Mesalazine—Malaise—Dexamethasone—atopic dermatitis	0.00011	0.000329	CcSEcCtD
Mesalazine—Malaise—Betamethasone—atopic dermatitis	0.00011	0.000329	CcSEcCtD
Mesalazine—CHUK—Innate Immune System—CASP1—atopic dermatitis	0.000109	0.000446	CbGpPWpGaD
Mesalazine—Oedema—Triamcinolone—atopic dermatitis	0.000109	0.000329	CcSEcCtD
Mesalazine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000109	0.000329	CcSEcCtD
Mesalazine—Vertigo—Betamethasone—atopic dermatitis	0.000109	0.000328	CcSEcCtD
Mesalazine—Vertigo—Dexamethasone—atopic dermatitis	0.000109	0.000328	CcSEcCtD
Mesalazine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000109	0.000328	CcSEcCtD
Mesalazine—Syncope—Betamethasone—atopic dermatitis	0.000109	0.000328	CcSEcCtD
Mesalazine—Syncope—Dexamethasone—atopic dermatitis	0.000109	0.000328	CcSEcCtD
Mesalazine—CHUK—Disease—GLB1—atopic dermatitis	0.000109	0.000444	CbGpPWpGaD
Mesalazine—Infection—Triamcinolone—atopic dermatitis	0.000109	0.000326	CcSEcCtD
Mesalazine—Hypotension—Hydrocortisone—atopic dermatitis	0.000109	0.000326	CcSEcCtD
Mesalazine—Infection—Methylprednisolone—atopic dermatitis	0.000108	0.000326	CcSEcCtD
Mesalazine—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	0.000108	0.00044	CbGpPWpGaD
Mesalazine—CHUK—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	0.000108	0.000439	CbGpPWpGaD
Mesalazine—Shock—Triamcinolone—atopic dermatitis	0.000108	0.000323	CcSEcCtD
Mesalazine—Insomnia—Prednisolone—atopic dermatitis	0.000108	0.000323	CcSEcCtD
Mesalazine—Alopecia—Prednisone—atopic dermatitis	0.000108	0.000323	CcSEcCtD
Mesalazine—Shock—Methylprednisolone—atopic dermatitis	0.000107	0.000323	CcSEcCtD
Mesalazine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000107	0.000321	CcSEcCtD
Mesalazine—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000107	0.000321	CcSEcCtD
Mesalazine—Loss of consciousness—Betamethasone—atopic dermatitis	0.000107	0.000321	CcSEcCtD
Mesalazine—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	0.000107	0.000435	CbGpPWpGaD
Mesalazine—Paraesthesia—Prednisolone—atopic dermatitis	0.000107	0.000321	CcSEcCtD
Mesalazine—Tachycardia—Triamcinolone—atopic dermatitis	0.000107	0.000321	CcSEcCtD
Mesalazine—Mental disorder—Prednisone—atopic dermatitis	0.000107	0.00032	CcSEcCtD
Mesalazine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000107	0.00032	CcSEcCtD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000106	0.000432	CbGpPWpGaD
Mesalazine—Skin disorder—Methylprednisolone—atopic dermatitis	0.000106	0.000318	CcSEcCtD
Mesalazine—Erythema—Prednisone—atopic dermatitis	0.000106	0.000318	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000106	0.000318	CcSEcCtD
Mesalazine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000106	0.000318	CcSEcCtD
Mesalazine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000106	0.000317	CcSEcCtD
Mesalazine—Insomnia—Hydrocortisone—atopic dermatitis	0.000105	0.000316	CcSEcCtD
Mesalazine—Hypertension—Betamethasone—atopic dermatitis	0.000105	0.000315	CcSEcCtD
Mesalazine—Hypertension—Dexamethasone—atopic dermatitis	0.000105	0.000315	CcSEcCtD
Mesalazine—CHUK—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	0.000105	0.000427	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	0.000105	0.000427	CbGpPWpGaD
Mesalazine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000104	0.000313	CcSEcCtD
Mesalazine—Myalgia—Betamethasone—atopic dermatitis	0.000104	0.000311	CcSEcCtD
Mesalazine—Myalgia—Dexamethasone—atopic dermatitis	0.000104	0.000311	CcSEcCtD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	0.000103	0.000421	CbGpPWpGaD
Mesalazine—Anxiety—Dexamethasone—atopic dermatitis	0.000103	0.00031	CcSEcCtD
Mesalazine—Anxiety—Betamethasone—atopic dermatitis	0.000103	0.00031	CcSEcCtD
Mesalazine—CHUK—TCR Signaling Pathway—IL6—atopic dermatitis	0.000103	0.00042	CbGpPWpGaD
Mesalazine—Discomfort—Betamethasone—atopic dermatitis	0.000102	0.000307	CcSEcCtD
Mesalazine—Discomfort—Dexamethasone—atopic dermatitis	0.000102	0.000307	CcSEcCtD
Mesalazine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000102	0.000307	CcSEcCtD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	0.000102	0.000416	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—NFKBIA—atopic dermatitis	0.000102	0.000415	CbGpPWpGaD
Mesalazine—Hypotension—Methylprednisolone—atopic dermatitis	0.000102	0.000306	CcSEcCtD
Mesalazine—Pain—Prednisolone—atopic dermatitis	0.000102	0.000306	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—TNF—atopic dermatitis	0.000101	0.000413	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—IL6—atopic dermatitis	0.000101	0.000412	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	0.000101	0.000412	CbGpPWpGaD
Mesalazine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000101	0.000303	CcSEcCtD
Mesalazine—IKBKB—BDNF signaling pathway—MAPK8—atopic dermatitis	0.0001	0.000409	CbGpPWpGaD
Mesalazine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.0001	0.000301	CcSEcCtD
Mesalazine—Fatigue—Hydrocortisone—atopic dermatitis	0.0001	0.000301	CcSEcCtD
Mesalazine—Vision blurred—Prednisone—atopic dermatitis	9.98e-05	0.0003	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	9.97e-05	0.000299	CcSEcCtD
Mesalazine—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	9.95e-05	0.000405	CbGpPWpGaD
Mesalazine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	9.95e-05	0.000299	CcSEcCtD
Mesalazine—Pain—Hydrocortisone—atopic dermatitis	9.94e-05	0.000298	CcSEcCtD
Mesalazine—IKBKB—Innate Immune System—CASP1—atopic dermatitis	9.93e-05	0.000404	CbGpPWpGaD
Mesalazine—Oedema—Betamethasone—atopic dermatitis	9.93e-05	0.000298	CcSEcCtD
Mesalazine—Oedema—Dexamethasone—atopic dermatitis	9.93e-05	0.000298	CcSEcCtD
Mesalazine—Anaphylactic shock—Betamethasone—atopic dermatitis	9.93e-05	0.000298	CcSEcCtD
Mesalazine—Anaphylactic shock—Dexamethasone—atopic dermatitis	9.93e-05	0.000298	CcSEcCtD
Mesalazine—CHUK—Innate Immune System—TLR2—atopic dermatitis	9.9e-05	0.000403	CbGpPWpGaD
Mesalazine—CHUK—Immune System—KIF3A—atopic dermatitis	9.9e-05	0.000403	CbGpPWpGaD
Mesalazine—Insomnia—Triamcinolone—atopic dermatitis	9.9e-05	0.000297	CcSEcCtD
Mesalazine—Insomnia—Methylprednisolone—atopic dermatitis	9.87e-05	0.000296	CcSEcCtD
Mesalazine—Infection—Betamethasone—atopic dermatitis	9.86e-05	0.000296	CcSEcCtD
Mesalazine—Infection—Dexamethasone—atopic dermatitis	9.86e-05	0.000296	CcSEcCtD
Mesalazine—Ill-defined disorder—Prednisone—atopic dermatitis	9.83e-05	0.000295	CcSEcCtD
Mesalazine—Paraesthesia—Triamcinolone—atopic dermatitis	9.82e-05	0.000295	CcSEcCtD
Mesalazine—Feeling abnormal—Prednisolone—atopic dermatitis	9.8e-05	0.000294	CcSEcCtD
Mesalazine—Paraesthesia—Methylprednisolone—atopic dermatitis	9.8e-05	0.000294	CcSEcCtD
Mesalazine—Anaemia—Prednisone—atopic dermatitis	9.79e-05	0.000294	CcSEcCtD
Mesalazine—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	9.78e-05	0.000398	CbGpPWpGaD
Mesalazine—Shock—Betamethasone—atopic dermatitis	9.77e-05	0.000293	CcSEcCtD
Mesalazine—Shock—Dexamethasone—atopic dermatitis	9.77e-05	0.000293	CcSEcCtD
Mesalazine—Dyspnoea—Triamcinolone—atopic dermatitis	9.75e-05	0.000293	CcSEcCtD
Mesalazine—Nervous system disorder—Dexamethasone—atopic dermatitis	9.73e-05	0.000292	CcSEcCtD
Mesalazine—Nervous system disorder—Betamethasone—atopic dermatitis	9.73e-05	0.000292	CcSEcCtD
Mesalazine—PPARG—Metabolism—GLB1—atopic dermatitis	9.73e-05	0.000396	CbGpPWpGaD
Mesalazine—Thrombocytopenia—Dexamethasone—atopic dermatitis	9.72e-05	0.000292	CcSEcCtD
Mesalazine—Thrombocytopenia—Betamethasone—atopic dermatitis	9.72e-05	0.000292	CcSEcCtD
Mesalazine—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	9.7e-05	0.000395	CbGpPWpGaD
Mesalazine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	9.69e-05	0.000395	CbGpPWpGaD
Mesalazine—Tachycardia—Dexamethasone—atopic dermatitis	9.69e-05	0.000291	CcSEcCtD
Mesalazine—Tachycardia—Betamethasone—atopic dermatitis	9.69e-05	0.000291	CcSEcCtD
Mesalazine—IKBKB—MAPK Signaling Pathway—IL1B—atopic dermatitis	9.69e-05	0.000394	CbGpPWpGaD
Mesalazine—Angioedema—Prednisone—atopic dermatitis	9.68e-05	0.000291	CcSEcCtD
Mesalazine—CHUK—Signaling Pathways—FCER2—atopic dermatitis	9.66e-05	0.000393	CbGpPWpGaD
Mesalazine—Dyspepsia—Triamcinolone—atopic dermatitis	9.63e-05	0.000289	CcSEcCtD
Mesalazine—Dyspepsia—Methylprednisolone—atopic dermatitis	9.61e-05	0.000289	CcSEcCtD
Mesalazine—Hyperhidrosis—Betamethasone—atopic dermatitis	9.6e-05	0.000288	CcSEcCtD
Mesalazine—Hyperhidrosis—Dexamethasone—atopic dermatitis	9.6e-05	0.000288	CcSEcCtD
Mesalazine—Feeling abnormal—Hydrocortisone—atopic dermatitis	9.57e-05	0.000288	CcSEcCtD
Mesalazine—Malaise—Prednisone—atopic dermatitis	9.55e-05	0.000287	CcSEcCtD
Mesalazine—CHUK—MyD88-independent cascade—IL6—atopic dermatitis	9.55e-05	0.000389	CbGpPWpGaD
Mesalazine—Vertigo—Prednisone—atopic dermatitis	9.52e-05	0.000286	CcSEcCtD
Mesalazine—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	9.51e-05	0.000387	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	9.5e-05	0.000285	CcSEcCtD
Mesalazine—Syncope—Prednisone—atopic dermatitis	9.5e-05	0.000285	CcSEcCtD
Mesalazine—Anorexia—Betamethasone—atopic dermatitis	9.46e-05	0.000284	CcSEcCtD
Mesalazine—Anorexia—Dexamethasone—atopic dermatitis	9.46e-05	0.000284	CcSEcCtD
Mesalazine—Urticaria—Prednisolone—atopic dermatitis	9.45e-05	0.000284	CcSEcCtD
Mesalazine—Fatigue—Triamcinolone—atopic dermatitis	9.43e-05	0.000283	CcSEcCtD
Mesalazine—Fatigue—Methylprednisolone—atopic dermatitis	9.41e-05	0.000283	CcSEcCtD
Mesalazine—PTGS2—Spinal Cord Injury—IFNG—atopic dermatitis	9.41e-05	0.000383	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	9.4e-05	0.000382	CbGpPWpGaD
Mesalazine—Pain—Triamcinolone—atopic dermatitis	9.36e-05	0.000281	CcSEcCtD
Mesalazine—IKBKB—TCR Signaling Pathway—IL6—atopic dermatitis	9.35e-05	0.00038	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ADSL—atopic dermatitis	9.33e-05	0.00038	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	9.32e-05	0.00038	CbGpPWpGaD
Mesalazine—Loss of consciousness—Prednisone—atopic dermatitis	9.31e-05	0.00028	CcSEcCtD
Mesalazine—Hypotension—Dexamethasone—atopic dermatitis	9.28e-05	0.000279	CcSEcCtD
Mesalazine—Hypotension—Betamethasone—atopic dermatitis	9.28e-05	0.000279	CcSEcCtD
Mesalazine—IKBKB—Signaling by NGF—NFKBIA—atopic dermatitis	9.25e-05	0.000377	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—MAPK8—atopic dermatitis	9.24e-05	0.000376	CbGpPWpGaD
Mesalazine—Urticaria—Hydrocortisone—atopic dermatitis	9.23e-05	0.000277	CcSEcCtD
Mesalazine—Body temperature increased—Hydrocortisone—atopic dermatitis	9.18e-05	0.000276	CcSEcCtD
Mesalazine—Abdominal pain—Hydrocortisone—atopic dermatitis	9.18e-05	0.000276	CcSEcCtD
Mesalazine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	9.18e-05	0.000374	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—IL6—atopic dermatitis	9.18e-05	0.000374	CbGpPWpGaD
Mesalazine—Hypertension—Prednisone—atopic dermatitis	9.15e-05	0.000275	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	9.04e-05	0.000272	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	9.04e-05	0.000272	CcSEcCtD
Mesalazine—PPARG—Circadian rythm related genes—MAPK8—atopic dermatitis	9.04e-05	0.000368	CbGpPWpGaD
Mesalazine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	9.03e-05	0.000367	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	9.02e-05	0.000367	CbGpPWpGaD
Mesalazine—Arthralgia—Prednisone—atopic dermatitis	9.02e-05	0.000271	CcSEcCtD
Mesalazine—Myalgia—Prednisone—atopic dermatitis	9.02e-05	0.000271	CcSEcCtD
Mesalazine—Feeling abnormal—Triamcinolone—atopic dermatitis	9.02e-05	0.000271	CcSEcCtD
Mesalazine—Feeling abnormal—Methylprednisolone—atopic dermatitis	9e-05	0.00027	CcSEcCtD
Mesalazine—Anxiety—Prednisone—atopic dermatitis	8.99e-05	0.00027	CcSEcCtD
Mesalazine—CHUK—Signaling Pathways—CCL22—atopic dermatitis	8.98e-05	0.000366	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TLR2—atopic dermatitis	8.98e-05	0.000366	CbGpPWpGaD
Mesalazine—Insomnia—Dexamethasone—atopic dermatitis	8.98e-05	0.00027	CcSEcCtD
Mesalazine—Insomnia—Betamethasone—atopic dermatitis	8.98e-05	0.00027	CcSEcCtD
Mesalazine—IKBKB—Immune System—KIF3A—atopic dermatitis	8.97e-05	0.000365	CbGpPWpGaD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	8.96e-05	0.000269	CcSEcCtD
Mesalazine—CHUK—Adaptive Immune System—CD79A—atopic dermatitis	8.94e-05	0.000364	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	8.93e-05	0.000268	CcSEcCtD
Mesalazine—Paraesthesia—Betamethasone—atopic dermatitis	8.91e-05	0.000268	CcSEcCtD
Mesalazine—Paraesthesia—Dexamethasone—atopic dermatitis	8.91e-05	0.000268	CcSEcCtD
Mesalazine—Discomfort—Prednisone—atopic dermatitis	8.91e-05	0.000268	CcSEcCtD
Mesalazine—CHUK—Signaling by Interleukins—IL6—atopic dermatitis	8.91e-05	0.000363	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—MAPK8—atopic dermatitis	8.88e-05	0.000362	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	8.84e-05	0.00036	CbGpPWpGaD
Mesalazine—Hypersensitivity—Prednisolone—atopic dermatitis	8.77e-05	0.000263	CcSEcCtD
Mesalazine—IKBKB—Signaling Pathways—FCER2—atopic dermatitis	8.76e-05	0.000357	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CXCL8—atopic dermatitis	8.75e-05	0.000356	CbGpPWpGaD
Mesalazine—Dyspepsia—Betamethasone—atopic dermatitis	8.74e-05	0.000262	CcSEcCtD
Mesalazine—Dyspepsia—Dexamethasone—atopic dermatitis	8.74e-05	0.000262	CcSEcCtD
Mesalazine—Urticaria—Triamcinolone—atopic dermatitis	8.69e-05	0.000261	CcSEcCtD
Mesalazine—Urticaria—Methylprednisolone—atopic dermatitis	8.67e-05	0.00026	CcSEcCtD
Mesalazine—IKBKB—MyD88-independent cascade—IL6—atopic dermatitis	8.66e-05	0.000353	CbGpPWpGaD
Mesalazine—Body temperature increased—Triamcinolone—atopic dermatitis	8.65e-05	0.00026	CcSEcCtD
Mesalazine—Oedema—Prednisone—atopic dermatitis	8.64e-05	0.00026	CcSEcCtD
Mesalazine—Anaphylactic shock—Prednisone—atopic dermatitis	8.64e-05	0.00026	CcSEcCtD
Mesalazine—Abdominal pain—Methylprednisolone—atopic dermatitis	8.63e-05	0.000259	CcSEcCtD
Mesalazine—Decreased appetite—Betamethasone—atopic dermatitis	8.63e-05	0.000259	CcSEcCtD
Mesalazine—Decreased appetite—Dexamethasone—atopic dermatitis	8.63e-05	0.000259	CcSEcCtD
Mesalazine—CHUK—Activated TLR4 signalling—IL6—atopic dermatitis	8.59e-05	0.00035	CbGpPWpGaD
Mesalazine—Infection—Prednisone—atopic dermatitis	8.59e-05	0.000258	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	8.57e-05	0.000257	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	8.57e-05	0.000257	CcSEcCtD
Mesalazine—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.56e-05	0.000257	CcSEcCtD
Mesalazine—Fatigue—Dexamethasone—atopic dermatitis	8.56e-05	0.000257	CcSEcCtD
Mesalazine—Fatigue—Betamethasone—atopic dermatitis	8.56e-05	0.000257	CcSEcCtD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	8.52e-05	0.000347	CbGpPWpGaD
Mesalazine—Shock—Prednisone—atopic dermatitis	8.51e-05	0.000255	CcSEcCtD
Mesalazine—Pain—Betamethasone—atopic dermatitis	8.49e-05	0.000255	CcSEcCtD
Mesalazine—Pain—Dexamethasone—atopic dermatitis	8.49e-05	0.000255	CcSEcCtD
Mesalazine—Nervous system disorder—Prednisone—atopic dermatitis	8.48e-05	0.000255	CcSEcCtD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	8.45e-05	0.000344	CbGpPWpGaD
Mesalazine—Tachycardia—Prednisone—atopic dermatitis	8.44e-05	0.000253	CcSEcCtD
Mesalazine—PPARG—Generic Transcription Pathway—PPARA—atopic dermatitis	8.43e-05	0.000343	CbGpPWpGaD
Mesalazine—CHUK—Immune System—STAT6—atopic dermatitis	8.42e-05	0.000343	CbGpPWpGaD
Mesalazine—Skin disorder—Prednisone—atopic dermatitis	8.4e-05	0.000252	CcSEcCtD
Mesalazine—PTGS2—Spinal Cord Injury—IL1B—atopic dermatitis	8.39e-05	0.000342	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL2—atopic dermatitis	8.36e-05	0.00034	CbGpPWpGaD
Mesalazine—Hyperhidrosis—Prednisone—atopic dermatitis	8.36e-05	0.000251	CcSEcCtD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	8.35e-05	0.00034	CbGpPWpGaD
Mesalazine—Asthenia—Hydrocortisone—atopic dermatitis	8.34e-05	0.00025	CcSEcCtD
Mesalazine—Anorexia—Prednisone—atopic dermatitis	8.24e-05	0.000247	CcSEcCtD
Mesalazine—Pruritus—Hydrocortisone—atopic dermatitis	8.22e-05	0.000247	CcSEcCtD
Mesalazine—CHUK—Immune System—CARD11—atopic dermatitis	8.19e-05	0.000333	CbGpPWpGaD
Mesalazine—Feeling abnormal—Betamethasone—atopic dermatitis	8.18e-05	0.000246	CcSEcCtD
Mesalazine—Feeling abnormal—Dexamethasone—atopic dermatitis	8.18e-05	0.000246	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—IL6—atopic dermatitis	8.18e-05	0.000333	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	8.18e-05	0.000333	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL22—atopic dermatitis	8.14e-05	0.000332	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Betamethasone—atopic dermatitis	8.12e-05	0.000244	CcSEcCtD
Mesalazine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	8.12e-05	0.000244	CcSEcCtD
Mesalazine—IKBKB—Adaptive Immune System—CD79A—atopic dermatitis	8.11e-05	0.00033	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	8.08e-05	0.000329	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL6—atopic dermatitis	8.08e-05	0.000329	CbGpPWpGaD
Mesalazine—Hypersensitivity—Triamcinolone—atopic dermatitis	8.06e-05	0.000242	CcSEcCtD
Mesalazine—Hypersensitivity—Methylprednisolone—atopic dermatitis	8.04e-05	0.000242	CcSEcCtD
Mesalazine—CHUK—Signaling Pathways—CCL27—atopic dermatitis	8e-05	0.000326	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	7.96e-05	0.000324	CbGpPWpGaD
Mesalazine—Diarrhoea—Hydrocortisone—atopic dermatitis	7.95e-05	0.000239	CcSEcCtD
Mesalazine—PPARG—Developmental Biology—PPARA—atopic dermatitis	7.94e-05	0.000323	CbGpPWpGaD
Mesalazine—Urticaria—Dexamethasone—atopic dermatitis	7.89e-05	0.000237	CcSEcCtD
Mesalazine—Urticaria—Betamethasone—atopic dermatitis	7.89e-05	0.000237	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	7.88e-05	0.000237	CcSEcCtD
Mesalazine—Dizziness—Prednisolone—atopic dermatitis	7.87e-05	0.000236	CcSEcCtD
Mesalazine—Asthenia—Triamcinolone—atopic dermatitis	7.85e-05	0.000236	CcSEcCtD
Mesalazine—Body temperature increased—Dexamethasone—atopic dermatitis	7.85e-05	0.000236	CcSEcCtD
Mesalazine—Abdominal pain—Betamethasone—atopic dermatitis	7.85e-05	0.000236	CcSEcCtD
Mesalazine—Abdominal pain—Dexamethasone—atopic dermatitis	7.85e-05	0.000236	CcSEcCtD
Mesalazine—Body temperature increased—Betamethasone—atopic dermatitis	7.85e-05	0.000236	CcSEcCtD
Mesalazine—Asthenia—Methylprednisolone—atopic dermatitis	7.83e-05	0.000235	CcSEcCtD
Mesalazine—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	7.83e-05	0.000319	CbGpPWpGaD
Mesalazine—Insomnia—Prednisone—atopic dermatitis	7.82e-05	0.000235	CcSEcCtD
Mesalazine—IKBKB—Activated TLR4 signalling—IL6—atopic dermatitis	7.79e-05	0.000317	CbGpPWpGaD
Mesalazine—Paraesthesia—Prednisone—atopic dermatitis	7.76e-05	0.000233	CcSEcCtD
Mesalazine—Pruritus—Triamcinolone—atopic dermatitis	7.74e-05	0.000232	CcSEcCtD
Mesalazine—Pruritus—Methylprednisolone—atopic dermatitis	7.72e-05	0.000232	CcSEcCtD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—atopic dermatitis	7.7e-05	0.000314	CbGpPWpGaD
Mesalazine—Dizziness—Hydrocortisone—atopic dermatitis	7.68e-05	0.000231	CcSEcCtD
Mesalazine—IKBKB—Immune System—STAT6—atopic dermatitis	7.63e-05	0.000311	CbGpPWpGaD
Mesalazine—Dyspepsia—Prednisone—atopic dermatitis	7.61e-05	0.000229	CcSEcCtD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	7.53e-05	0.000307	CbGpPWpGaD
Mesalazine—Decreased appetite—Prednisone—atopic dermatitis	7.51e-05	0.000226	CcSEcCtD
Mesalazine—Rash—Prednisolone—atopic dermatitis	7.5e-05	0.000225	CcSEcCtD
Mesalazine—Dermatitis—Prednisolone—atopic dermatitis	7.49e-05	0.000225	CcSEcCtD
Mesalazine—Diarrhoea—Methylprednisolone—atopic dermatitis	7.47e-05	0.000224	CcSEcCtD
Mesalazine—Fatigue—Prednisone—atopic dermatitis	7.45e-05	0.000224	CcSEcCtD
Mesalazine—Headache—Prednisolone—atopic dermatitis	7.45e-05	0.000224	CcSEcCtD
Mesalazine—IKBKB—Immune System—CARD11—atopic dermatitis	7.42e-05	0.000302	CbGpPWpGaD
Mesalazine—Constipation—Prednisone—atopic dermatitis	7.39e-05	0.000222	CcSEcCtD
Mesalazine—Vomiting—Hydrocortisone—atopic dermatitis	7.39e-05	0.000222	CcSEcCtD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	7.33e-05	0.000298	CbGpPWpGaD
Mesalazine—Rash—Hydrocortisone—atopic dermatitis	7.33e-05	0.00022	CcSEcCtD
Mesalazine—Dermatitis—Hydrocortisone—atopic dermatitis	7.32e-05	0.00022	CcSEcCtD
Mesalazine—CHUK—Disease—SLC11A1—atopic dermatitis	7.3e-05	0.000297	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	7.28e-05	0.000296	CbGpPWpGaD
Mesalazine—Headache—Hydrocortisone—atopic dermatitis	7.28e-05	0.000219	CcSEcCtD
Mesalazine—IKBKB—Signaling Pathways—CCL27—atopic dermatitis	7.26e-05	0.000295	CbGpPWpGaD
Mesalazine—Dizziness—Triamcinolone—atopic dermatitis	7.23e-05	0.000217	CcSEcCtD
Mesalazine—Dizziness—Methylprednisolone—atopic dermatitis	7.22e-05	0.000217	CcSEcCtD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	7.22e-05	0.000294	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD8A—atopic dermatitis	7.21e-05	0.000293	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—IL6—atopic dermatitis	7.2e-05	0.000293	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—IL6—atopic dermatitis	7.2e-05	0.000293	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL17—atopic dermatitis	7.18e-05	0.000292	CbGpPWpGaD
Mesalazine—Feeling abnormal—Prednisone—atopic dermatitis	7.12e-05	0.000214	CcSEcCtD
Mesalazine—Asthenia—Betamethasone—atopic dermatitis	7.12e-05	0.000214	CcSEcCtD
Mesalazine—Asthenia—Dexamethasone—atopic dermatitis	7.12e-05	0.000214	CcSEcCtD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	7.1e-05	0.000289	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.09e-05	0.000289	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL2—atopic dermatitis	7.07e-05	0.000288	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Prednisone—atopic dermatitis	7.07e-05	0.000212	CcSEcCtD
Mesalazine—Nausea—Prednisolone—atopic dermatitis	7.07e-05	0.000212	CcSEcCtD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—atopic dermatitis	7.03e-05	0.000286	CbGpPWpGaD
Mesalazine—Pruritus—Betamethasone—atopic dermatitis	7.02e-05	0.000211	CcSEcCtD
Mesalazine—Pruritus—Dexamethasone—atopic dermatitis	7.02e-05	0.000211	CcSEcCtD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	7e-05	0.000285	CbGpPWpGaD
Mesalazine—Vomiting—Triamcinolone—atopic dermatitis	6.96e-05	0.000209	CcSEcCtD
Mesalazine—Vomiting—Methylprednisolone—atopic dermatitis	6.94e-05	0.000208	CcSEcCtD
Mesalazine—Nausea—Hydrocortisone—atopic dermatitis	6.9e-05	0.000207	CcSEcCtD
Mesalazine—Rash—Triamcinolone—atopic dermatitis	6.9e-05	0.000207	CcSEcCtD
Mesalazine—Dermatitis—Triamcinolone—atopic dermatitis	6.89e-05	0.000207	CcSEcCtD
Mesalazine—CHUK—Downstream signaling of activated FGFR—IL6—atopic dermatitis	6.89e-05	0.00028	CbGpPWpGaD
Mesalazine—Rash—Methylprednisolone—atopic dermatitis	6.88e-05	0.000207	CcSEcCtD
Mesalazine—Dermatitis—Methylprednisolone—atopic dermatitis	6.88e-05	0.000206	CcSEcCtD
Mesalazine—Urticaria—Prednisone—atopic dermatitis	6.87e-05	0.000206	CcSEcCtD
Mesalazine—Headache—Triamcinolone—atopic dermatitis	6.85e-05	0.000206	CcSEcCtD
Mesalazine—Headache—Methylprednisolone—atopic dermatitis	6.84e-05	0.000205	CcSEcCtD
Mesalazine—Abdominal pain—Prednisone—atopic dermatitis	6.83e-05	0.000205	CcSEcCtD
Mesalazine—Body temperature increased—Prednisone—atopic dermatitis	6.83e-05	0.000205	CcSEcCtD
Mesalazine—PTGS1—Metabolism—GLB1—atopic dermatitis	6.81e-05	0.000277	CbGpPWpGaD
Mesalazine—Diarrhoea—Dexamethasone—atopic dermatitis	6.79e-05	0.000204	CcSEcCtD
Mesalazine—Diarrhoea—Betamethasone—atopic dermatitis	6.79e-05	0.000204	CcSEcCtD
Mesalazine—CHUK—Signaling by ERBB4—IL6—atopic dermatitis	6.78e-05	0.000276	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	6.6e-05	0.000269	CbGpPWpGaD
Mesalazine—Dizziness—Betamethasone—atopic dermatitis	6.56e-05	0.000197	CcSEcCtD
Mesalazine—Dizziness—Dexamethasone—atopic dermatitis	6.56e-05	0.000197	CcSEcCtD
Mesalazine—IKBKB—Adaptive Immune System—CD8A—atopic dermatitis	6.53e-05	0.000266	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ADSL—atopic dermatitis	6.53e-05	0.000266	CbGpPWpGaD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—IL6—atopic dermatitis	6.53e-05	0.000266	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL17—atopic dermatitis	6.51e-05	0.000265	CbGpPWpGaD
Mesalazine—Nausea—Triamcinolone—atopic dermatitis	6.5e-05	0.000195	CcSEcCtD
Mesalazine—Nausea—Methylprednisolone—atopic dermatitis	6.48e-05	0.000195	CcSEcCtD
Mesalazine—CHUK—Downstream signal transduction—IL6—atopic dermatitis	6.47e-05	0.000263	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GLB1—atopic dermatitis	6.46e-05	0.000263	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—IL6—atopic dermatitis	6.44e-05	0.000262	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	6.44e-05	0.000262	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL2—atopic dermatitis	6.41e-05	0.000261	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—atopic dermatitis	6.41e-05	0.000261	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—MAPK8—atopic dermatitis	6.4e-05	0.000261	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—KIF3A—atopic dermatitis	6.4e-05	0.000261	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CASP1—atopic dermatitis	6.38e-05	0.00026	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—IL6—atopic dermatitis	6.38e-05	0.00026	CbGpPWpGaD
Mesalazine—Hypersensitivity—Prednisone—atopic dermatitis	6.37e-05	0.000191	CcSEcCtD
Mesalazine—Vomiting—Betamethasone—atopic dermatitis	6.31e-05	0.00019	CcSEcCtD
Mesalazine—Vomiting—Dexamethasone—atopic dermatitis	6.31e-05	0.00019	CcSEcCtD
Mesalazine—Rash—Dexamethasone—atopic dermatitis	6.26e-05	0.000188	CcSEcCtD
Mesalazine—Rash—Betamethasone—atopic dermatitis	6.26e-05	0.000188	CcSEcCtD
Mesalazine—Dermatitis—Betamethasone—atopic dermatitis	6.25e-05	0.000188	CcSEcCtD
Mesalazine—Dermatitis—Dexamethasone—atopic dermatitis	6.25e-05	0.000188	CcSEcCtD
Mesalazine—Headache—Betamethasone—atopic dermatitis	6.22e-05	0.000187	CcSEcCtD
Mesalazine—Headache—Dexamethasone—atopic dermatitis	6.22e-05	0.000187	CcSEcCtD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—atopic dermatitis	6.22e-05	0.000253	CbGpPWpGaD
Mesalazine—Asthenia—Prednisone—atopic dermatitis	6.2e-05	0.000186	CcSEcCtD
Mesalazine—Pruritus—Prednisone—atopic dermatitis	6.12e-05	0.000184	CcSEcCtD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—atopic dermatitis	6.09e-05	0.000248	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL5—atopic dermatitis	6.05e-05	0.000246	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	6e-05	0.000244	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—atopic dermatitis	6e-05	0.000244	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—atopic dermatitis	6e-05	0.000244	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—IL6—atopic dermatitis	5.95e-05	0.000242	CbGpPWpGaD
Mesalazine—Diarrhoea—Prednisone—atopic dermatitis	5.91e-05	0.000178	CcSEcCtD
Mesalazine—Nausea—Dexamethasone—atopic dermatitis	5.9e-05	0.000177	CcSEcCtD
Mesalazine—Nausea—Betamethasone—atopic dermatitis	5.9e-05	0.000177	CcSEcCtD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—atopic dermatitis	5.89e-05	0.00024	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—atopic dermatitis	5.87e-05	0.000239	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—NFKBIA—atopic dermatitis	5.82e-05	0.000237	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—MAPK8—atopic dermatitis	5.8e-05	0.000236	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KIF3A—atopic dermatitis	5.8e-05	0.000236	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CMA1—atopic dermatitis	5.79e-05	0.000236	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL11—atopic dermatitis	5.79e-05	0.000236	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CASP1—atopic dermatitis	5.78e-05	0.000235	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—IL6—atopic dermatitis	5.77e-05	0.000235	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TLR2—atopic dermatitis	5.77e-05	0.000235	CbGpPWpGaD
Mesalazine—Dizziness—Prednisone—atopic dermatitis	5.72e-05	0.000172	CcSEcCtD
Mesalazine—CHUK—Adaptive Immune System—NFKBIA—atopic dermatitis	5.59e-05	0.000227	CbGpPWpGaD
Mesalazine—Vomiting—Prednisone—atopic dermatitis	5.5e-05	0.000165	CcSEcCtD
Mesalazine—IKBKB—Immune System—IL5—atopic dermatitis	5.48e-05	0.000223	CbGpPWpGaD
Mesalazine—Rash—Prednisone—atopic dermatitis	5.45e-05	0.000164	CcSEcCtD
Mesalazine—Dermatitis—Prednisone—atopic dermatitis	5.45e-05	0.000164	CcSEcCtD
Mesalazine—CHUK—Signaling Pathways—STAT6—atopic dermatitis	5.44e-05	0.000222	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	5.44e-05	0.000221	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD79A—atopic dermatitis	5.42e-05	0.000221	CbGpPWpGaD
Mesalazine—Headache—Prednisone—atopic dermatitis	5.42e-05	0.000163	CcSEcCtD
Mesalazine—PTGS2—Metabolism—GLB1—atopic dermatitis	5.41e-05	0.00022	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	5.31e-05	0.000216	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—NFKBIA—atopic dermatitis	5.28e-05	0.000215	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CASP8—atopic dermatitis	5.25e-05	0.000214	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL11—atopic dermatitis	5.25e-05	0.000214	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CMA1—atopic dermatitis	5.25e-05	0.000214	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	5.24e-05	0.000213	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TLR2—atopic dermatitis	5.23e-05	0.000213	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ADSL—atopic dermatitis	5.19e-05	0.000211	CbGpPWpGaD
Mesalazine—Nausea—Prednisone—atopic dermatitis	5.13e-05	0.000154	CcSEcCtD
Mesalazine—ALOX5—Metabolism—PPARA—atopic dermatitis	5.1e-05	0.000208	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—NFKBIA—atopic dermatitis	5.07e-05	0.000206	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.97e-05	0.000202	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—STAT6—atopic dermatitis	4.93e-05	0.000201	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD79A—atopic dermatitis	4.92e-05	0.0002	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—atopic dermatitis	4.92e-05	0.0002	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CASP8—atopic dermatitis	4.76e-05	0.000194	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR3—atopic dermatitis	4.72e-05	0.000192	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL18—atopic dermatitis	4.44e-05	0.000181	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD8A—atopic dermatitis	4.37e-05	0.000178	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SLC11A1—atopic dermatitis	4.33e-05	0.000176	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD4—atopic dermatitis	4.31e-05	0.000175	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR3—atopic dermatitis	4.28e-05	0.000174	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NPS—atopic dermatitis	4.2e-05	0.000171	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TAC1—atopic dermatitis	4.2e-05	0.000171	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—atopic dermatitis	4.16e-05	0.000169	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	4.14e-05	0.000169	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD4—atopic dermatitis	4.14e-05	0.000169	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCR3—atopic dermatitis	4.12e-05	0.000168	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—atopic dermatitis	4.09e-05	0.000166	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—PPARA—atopic dermatitis	4.06e-05	0.000165	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL18—atopic dermatitis	4.02e-05	0.000164	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD8A—atopic dermatitis	3.96e-05	0.000161	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.94e-05	0.00016	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL5—atopic dermatitis	3.91e-05	0.000159	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD4—atopic dermatitis	3.91e-05	0.000159	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NPS—atopic dermatitis	3.81e-05	0.000155	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TAC1—atopic dermatitis	3.81e-05	0.000155	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—atopic dermatitis	3.77e-05	0.000153	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD4—atopic dermatitis	3.75e-05	0.000153	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCR3—atopic dermatitis	3.74e-05	0.000152	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—atopic dermatitis	3.71e-05	0.000151	CbGpPWpGaD
Mesalazine—CHUK—Disease—CCR5—atopic dermatitis	3.69e-05	0.00015	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—MAPK8—atopic dermatitis	3.65e-05	0.000149	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL5—atopic dermatitis	3.54e-05	0.000144	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—atopic dermatitis	3.48e-05	0.000142	CbGpPWpGaD
Mesalazine—CHUK—Immune System—NFKBIA—atopic dermatitis	3.39e-05	0.000138	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL10—atopic dermatitis	3.33e-05	0.000136	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—MAPK8—atopic dermatitis	3.31e-05	0.000135	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PPARA—atopic dermatitis	3.16e-05	0.000129	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—NFKBIA—atopic dermatitis	3.07e-05	0.000125	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CASP8—atopic dermatitis	3.06e-05	0.000124	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL10—atopic dermatitis	3.02e-05	0.000123	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL5—atopic dermatitis	2.87e-05	0.000117	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—atopic dermatitis	2.81e-05	0.000114	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CASP8—atopic dermatitis	2.77e-05	0.000113	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NGF—atopic dermatitis	2.66e-05	0.000108	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL5—atopic dermatitis	2.6e-05	0.000106	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNG—atopic dermatitis	2.6e-05	0.000106	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR5—atopic dermatitis	2.58e-05	0.000105	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD4—atopic dermatitis	2.51e-05	0.000102	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NGF—atopic dermatitis	2.41e-05	9.81e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNG—atopic dermatitis	2.36e-05	9.6e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR5—atopic dermatitis	2.34e-05	9.54e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—atopic dermatitis	2.33e-05	9.49e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—atopic dermatitis	2.32e-05	9.44e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD4—atopic dermatitis	2.32e-05	9.44e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2—atopic dermatitis	2.31e-05	9.4e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD4—atopic dermatitis	2.28e-05	9.27e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARA—atopic dermatitis	2.21e-05	9e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NFKBIA—atopic dermatitis	2.19e-05	8.92e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CCR5—atopic dermatitis	2.19e-05	8.9e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—MAPK8—atopic dermatitis	2.13e-05	8.66e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—atopic dermatitis	2.11e-05	8.61e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—atopic dermatitis	2.1e-05	8.56e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2—atopic dermatitis	2.09e-05	8.53e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NFKBIA—atopic dermatitis	1.99e-05	8.09e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MAPK8—atopic dermatitis	1.93e-05	7.85e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARA—atopic dermatitis	1.76e-05	7.15e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL8—atopic dermatitis	1.56e-05	6.36e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2—atopic dermatitis	1.49e-05	6.08e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL8—atopic dermatitis	1.42e-05	5.77e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MAPK8—atopic dermatitis	1.37e-05	5.6e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD4—atopic dermatitis	1.37e-05	5.59e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—atopic dermatitis	1.36e-05	5.53e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2—atopic dermatitis	1.35e-05	5.51e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—atopic dermatitis	1.25e-05	5.1e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MAPK8—atopic dermatitis	1.25e-05	5.07e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—atopic dermatitis	1.23e-05	5.01e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—atopic dermatitis	8.78e-06	3.57e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—atopic dermatitis	7.96e-06	3.24e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—atopic dermatitis	7.43e-06	3.02e-05	CbGpPWpGaD
